Scinai Immunotherapeutics Ltd. Share Price
Stocks
SCNI
US09073Q4029
Biotechnology & Medical Research
|
Market Closed -
Nasdaq
21:00:00 05/10/2026 BST
|
5-day change | 1st Jan Change | ||
| 1.260 USD | -5.26% |
|
-18.71% | -82.31% |
| 08-26 | Scinai Immunotherapeutics Ltd., H1 2026 Earnings Call, Aug 26, 2026 | |
| 08-24 | Scinai Immunotherapeutics Ltd. Reports Earnings Results for the Half Year Ended June 30, 2026 | CI |
| Market Cap | 758K 676K 630K 574K 1.08M 73.01M 1.09M 7.6M 2.96M 37.25M 2.85M 2.78M 120M | P/E 2024 * |
-
| P/E 2025 | -0.2x |
|---|---|---|---|---|---|
| Enterprise Value | 1.36M 1.22M 1.13M 1.03M 1.94M 131M 1.96M 13.68M 5.32M 67.03M 5.12M 5.01M 215M | EV / Sales 2024 |
4,521,658x | EV / Sales 2025 | 2,346,086x |
| Free-Float |
0.36% | Yield 2024 * |
-
| Yield 2025 | - |
NasdaqUSD
| Markets | Quality | ||
|---|---|---|---|
Nasdaq
| SCNI | Delayed | |
CBOE
| SCNI | Real-time | |
|
Deutsche Boerse AG
| 2F50 | Delayed |
Last Transcript: Scinai Immunotherapeutics Ltd.
| 1 day | -5.26% | ||
| 1 week | -18.71% | ||
| Current month | -11.27% | ||
| 1 month | -32.26% | ||
| 3 months | -53.40% | ||
| 6 months | -79.00% | ||
| Current year | -82.31% |
| 1 week | 1.26 |  | 1.5 |
| 1 month | 1.26 | | 2.67 |
| Current year | 1.26 | | 11.2 |
| 1 year | 1.26 | | 16.3 |
| 3 years | 1.26 | | 89.2 |
| 5 years | 1.26 | | 3,490 |
| 10 years | 1.26 | | 61,999.9 |
| Manager | Title | Age | Since |
|---|---|---|---|
Amir Reichman
CEO | Chief Executive Officer | 51 | 01/03/2021 |
Uri Ben-Or
DFI | Director of Finance/CFO | 55 | 31/12/2006 |
Dalit Fischer
CTO | Chief Tech/Sci/R&D Officer | - | 31/12/2021 |
| Director | Title | Age | Since |
|---|---|---|---|
Mark Germain
CHM | Chairman | 77 | 29/09/2019 |
Samuel Moed
BRD | Director/Board Member | 64 | 23/03/2020 |
Adi Raviv
BRD | Director/Board Member | 71 | 23/03/2020 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | Importance |
|---|---|---|---|---|---|---|
| 18/03/26 | Other | Chief Financial Officer | 35,848,348 | 1.0507% | ||
| 18/03/26 | Other | Director | 57,400,000 | 1.6823% | ||
| 18/03/26 | Other | Director | 60,400,000 | 1.7702% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -5.26% | -18.71% | -90.53% | -98.32% | 758K | |
| +4.16% | +3.04% | +49.37% | +94.17% | 74.16B | |
| -0.37% | -3.88% | +19.75% | +78.35% | 57.39B | |
| +1.63% | +0.98% | +3.83% | +38.21% | 47.64B | |
| +0.50% | +1.32% | +344.62% | +753.25% | 44.29B | |
| +3.05% | -1.58% | +28.78% | +35.46% | 42.5B | |
| +1.00% | +0.22% | +5.17% | +113.80% | 40.71B | |
| -0.54% | +2.93% | +9.31% | +54.06% | 30.97B | |
| +1.56% | +4.53% | +31.34% | +26.92% | 28.53B | |
| +0.76% | -0.89% | -7.44% | -11.43% | 24.34B | |
| Average | +0.65% | -1.95% | +39.42% | +108.45% | 39.05B | |
| Weighted average by Cap. | +1.55% | -0.84% | +58.06% | +140.75% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 0.66 0.59 0.55 0.5 0.94 63.37 0.94 6.6 2.57 32.33 2.47 2.42 103.87 | 1.31 1.17 1.09 0.99 1.87 126.25 1.88 13.15 5.11 64.42 4.92 4.82 206.95 |
| Net income | 4.8M 4.27M 3.98M 3.63M 6.83M 462M 6.88M 48.11M 18.71M 236M 18M 17.61M 757M | -8.31M -7.4M -6.9M -6.28M -11.84M -800M -11.92M -83.33M -32.4M -408M -31.19M -30.51M -1.31B |
| Net Debt | 122K 109K 101K 92.3K 174K 11.75M 175K 1.22M 476K 5.99M 458K 448K 19.26M | 606K 540K 503K 458K 864K 58.36M 870K 6.08M 2.36M 29.78M 2.27M 2.23M 95.66M |
Employees
45
| Date | Price | Change | Volume |
|---|---|---|---|
| 05/10/26 | US$1.260 | -5.26% | 33,518 |
| 02/10/26 | US$1.330 | +1.53% | 22,168 |
| 01/10/26 | US$1.310 | -7.75% | 43,751 |
| 30/09/26 | US$1.420 | +0.71% | 80,134 |
| 29/09/26 | US$1.410 | -4.08% | 98,629 |
Annual profits - Rate of surprise
- Stock Market
- Stocks
- SCNI Stock
Select your edition
All financial news and data tailored to specific country editions
